{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:10:33Z","timestamp":1778202633336,"version":"3.51.4"},"reference-count":267,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cjca.2025.05.020","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T19:33:49Z","timestamp":1768332829000},"page":"101-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-688X","authenticated-orcid":false,"given":"Jacqueline","family":"Joza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Philippon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimie","family":"Manlucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Mond\u00e9sert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhannad M.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratika","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Greiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Ayala-Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarence","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Kulyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mardell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Murtagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calum","family":"Redpath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopinder K.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence D.","family":"Sterns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Terricabras Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.05.020_bib1","article-title":"The Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients with Cardiac Implantable Electronic Devices","author":"Andrade","year":"2026","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jacc.2003.11.038","article-title":"Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II)","volume":"43","author":"Greenberg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib9","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib12","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib13","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib16","doi-asserted-by":"crossref","first-page":"f211","DOI":"10.1093\/europace\/eux324","article-title":"Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials","volume":"20","author":"Romero","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12471-022-01718-3","article-title":"Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy: an updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology","volume":"31","author":"Theuns","year":"2023","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacep.2017.02.006","article-title":"Efficacy of implantable cardioverter-defibrillator therapy in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Anantha Narayanan","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib19","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.119.043012","article-title":"Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score-matched analysis from the Swedish Heart Failure Registry","volume":"140","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib20","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib21","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.2014.5310","article-title":"Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%","volume":"311","author":"Al-Khatib","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2025.05.020_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCULATIONAHA.117.031786","article-title":"Centers for Medicare and Medicaid Services\u2019 decision to reconsider coverage indications for ICDs: where to now?","volume":"137","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib23","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.hrthm.2022.04.022","article-title":"2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders","volume":"19","author":"Groh","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib24","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib26","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib27","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"van den Hoogenhof","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003589","article-title":"Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in TMEM43 following implantable cardioverter defibrillator therapy","volume":"9","author":"Hodgkinson","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib29","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2020.06.015","article-title":"Sacubitril\/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: a PARADIGM-HF analysis","volume":"8","author":"Rohde","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2025.05.020_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.122.062159","article-title":"Declining risk of sudden cardiac death in heart failure: fact or myth?","volume":"147","author":"Leyva","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib35","first-page":"399","article-title":"Implantable cardioverter-defibrillators in octogenarians: an appeal for a randomized clinical trial","volume":"40","author":"Gula","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib36","first-page":"389","article-title":"Outcomes following implantable cardioverter-defibrillator insertion in patients 80 years of age or older: a statewide population cohort study","volume":"40","author":"Vijayarajan","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib37","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/eurheartj\/ehaa1057","article-title":"Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD Benefit Score","volume":"42","author":"Younis","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib38","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jacc.2012.07.028","article-title":"Prediction of mortality in clinical practice for Medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death","volume":"60","author":"Bilchick","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib39","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jacc.2017.03.568","article-title":"Seattle Heart Failure and Proportional risk models predict benefit from implantable cardioverter-defibrillators","volume":"69","author":"Bilchick","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2020.03.060","article-title":"Prognostic value of Charlson Comorbidity Index in the elderly with a cardioverter defibrillator implantation","volume":"314","author":"Poupin","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib41","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib42","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1093\/eurheartj\/ehae326","article-title":"Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts","volume":"45","author":"Peek","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1172\/JCI116540","article-title":"Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy","volume":"92","author":"Anderson","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2025.05.020_bib44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis","volume":"11","author":"Becker","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.05.020_bib45","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib46","first-page":"162","article-title":"Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial, Am Heart","volume":"291","author":"Goldenberg","year":"2025","journal-title":"J"},{"key":"10.1016\/j.cjca.2025.05.020_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2023.09.008","volume":"266","author":"Flett","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib49","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.hrthm.2015.12.048","article-title":"Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy","volume":"13","author":"Maron","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib51","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib52","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.hrthm.2021.01.019","article-title":"Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: twenty years with the implantable cardioverter-defibrillator","volume":"18","author":"Maron","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib53","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib54","first-page":"31","article-title":"Implantable cardioverter-defibrillator in hypertrophic cardiomyopathy","volume":"2018","author":"Sanchez","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.cjca.2025.05.020_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hrthm.2020.08.009","article-title":"Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-are there predictors of appropriate therapy?","volume":"18","author":"Weissler-Snir","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib56","first-page":"2106","article-title":"Navigating the landscape of medical device advisories: a special report from the Canadian Heart Rhythm Society Device Advisory Committee","volume":"40","author":"Andrade","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib57","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib58","first-page":"e533","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib59","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.117.030437","article-title":"International external validation study of the 2014 European Society of Cardiology guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy (EVIDENCE-HCM)","volume":"137","author":"O\u2019Mahony","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.691653","article-title":"Validation of the 2020 AHA\/ACC risk stratification for sudden cardiac death in Chinese patients with hypertrophic cardiomyopathy","volume":"8","author":"Dong","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hjc.2021.06.005","article-title":"Validation of the new American College of Cardiology\/American Heart Association guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with hypertrophic cardiomyopathy","volume":"63","author":"Zegkos","year":"2022","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib62","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1093\/eurheartj\/ehad581","article-title":"Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines","volume":"44","author":"Wang","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib63","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib65","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jjcc.2014.02.011","article-title":"Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography","volume":"64","author":"Ichida","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib68","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1111\/chd.12242","article-title":"Genotype-phenotype correlations in apical variant hypertrophic cardiomyopathy","volume":"10","author":"Towe","year":"2015","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.cjca.2025.05.020_bib69","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.amjcard.2023.10.076","article-title":"The paradigm of sudden death prevention in hypertrophic cardiomyopathy","volume":"212S","author":"Maron","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pcad.2023.08.005","article-title":"Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: current state, unknowns, and future directions","volume":"80","author":"Siontis","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2025.05.020_bib71","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib72","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib73","first-page":"1791","article-title":"Variable and limited predictive value of the European Society of Cardiology hypertrophic cardiomyopathy sudden-death risk model: a meta-analysis","volume":"35","author":"Wang","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccep.2023.04.010","article-title":"Sudden death risk assessment in hypertrophic cardiomyopathy across the lifespan: reconciling the American and European approaches","volume":"15","author":"Al Samarraie","year":"2023","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.cjca.2025.05.020_bib75","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib77","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.amjcard.2015.11.013","article-title":"What do patients with hypertrophic cardiomyopathy die from?","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib78","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012041","article-title":"Impact of sex on clinical course and survival in the contemporary treatment era for hypertrophic cardiomyopathy","volume":"8","author":"Rowin","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.05.020_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131265","article-title":"Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: an observational cross-sectional study","volume":"391","author":"Khoury","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib81","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.117.032838","article-title":"Association between race and clinical profile of patients referred for hypertrophic cardiomyopathy","volume":"137","author":"Wells","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.548564","article-title":"Ventricular arrhythmia in septal and apical hypertrophic cardiomyopathy: the French-Canadian experience","volume":"7","author":"Steinberg","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00392-023-02310-4","article-title":"Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information","volume":"113","author":"Amr","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib84","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033565","article-title":"Relationship between genotype status and clinical outcome in hypertrophic cardiomyopathy","volume":"13","author":"Bonaventura","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.05.020_bib85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib87","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib88","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10741-018-09767-w","article-title":"Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy","volume":"24","author":"Rigopoulos","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2025.05.020_bib90","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jtcvs.2018.03.150","article-title":"Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: potential for refinement of current criteria","volume":"156","author":"Desai","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.05.020_bib91","doi-asserted-by":"crossref","first-page":"f198","DOI":"10.1093\/europace\/eux251","article-title":"Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation","volume":"20","author":"Liebregts","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib92","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.jacc.2019.10.011","article-title":"Precision medicine in the management of dilated cardiomyopathy: JACC State-of-the-Art Review","volume":"74","author":"Fatkin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib94","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCGEN.123.004059","article-title":"Risks of ventricular arrhythmia and heart failure in carriers of RBM20 variants","volume":"16","author":"Cannie","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib96","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","article-title":"Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations","volume":"72","author":"Dominguez","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib97","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib98","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2025.05.020_bib99","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib100","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/eurheartj\/ehac298","article-title":"Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?","volume":"43","author":"Corrado","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib101","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/heartjnl-2017-312338","article-title":"Lamin and the heart","volume":"104","author":"Captur","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2025.05.020_bib102","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib103","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI37679","article-title":"Laminopathies and the long strange trip from basic cell biology to therapy","volume":"119","author":"Worman","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjca.2025.05.020_bib104","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.0000000000000934","article-title":"LMNA-associated myopathies: the Italian experience in a large cohort of patients","volume":"83","author":"Maggi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.cjca.2025.05.020_bib105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M18-2768","article-title":"Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy","volume":"171","author":"Peretto","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1135438","article-title":"LMNA-related muscular dystrophy: identification of variants in alternative genes and personalized clinical translation","volume":"14","author":"Cesar","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jacbts.2018.12.001","article-title":"Characterization of a unique form of arrhythmic cardiomyopathy caused by recessive mutation in LEMD2","volume":"4","author":"Abdelfatah","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cjca.2025.05.020_bib108","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib109","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib110","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib111","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib112","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hrthm.2022.11.024","article-title":"Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies-external validation of the LMNA-risk ventricular tachyarrhythmia calculator","volume":"20","author":"Rootwelt-Norberg","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib113","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cjca.2025.05.020_bib114","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","article-title":"Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes","volume":"6","author":"Posch","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib116","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","article-title":"Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma","volume":"9","author":"Norgett","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib117","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib118","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/europace\/euu128","article-title":"Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype","volume":"16","author":"Lopez-Ayala","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib119","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib120","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/eurheartj\/ehi341","article-title":"Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations","volume":"26","author":"Bauce","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib121","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.hrthm.2022.04.015","article-title":"Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy","volume":"19","author":"Bariani","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib122","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/europace\/euab183","article-title":"Clinical characteristics and risk stratification of desmoplakin cardiomyopathy","volume":"24","author":"Wang","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib123","first-page":"326","article-title":"Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study","volume":"21","author":"Augusto","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.05.020_bib124","first-page":"2968","article-title":"A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/431959","article-title":"A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy","volume":"77","author":"Vorgerd","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cge.13594","article-title":"FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations","volume":"96","author":"Ader","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib127","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001780","article-title":"Novel mutation in FLNC (filamin C) causes familial restrictive cardiomyopathy","volume":"10","author":"Tucker","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2025.05.020_bib128","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003645","article-title":"Loss-of-function FLNC variants are associated with arrhythmogenic cardiomyopathy phenotypes when identified through exome sequencing of a general clinical population","volume":"15","author":"Carruth","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib129","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.121.053521","article-title":"Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by filamin C truncating variants","volume":"144","author":"Gigli","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib130","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamacardio.2021.1106","article-title":"Association of left ventricular systolic dysfunction among carriers of truncating variants in filamin C with frequent ventricular arrhythmia and end-stage heart failure","volume":"6","author":"Akhtar","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib131","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.jacc.2021.04.030","article-title":"Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy","volume":"77","author":"Di Marco","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib132","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/europace\/euad043","article-title":"EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS)","volume":"25","author":"Burri","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib133","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jce.16128","article-title":"Left bundle branch pacing versus left ventricular septal pacing as a primary procedural endpoint during left bundle branch area pacing: evaluation of two different implant strategies","volume":"35","author":"Cano","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib134","doi-asserted-by":"crossref","first-page":"172","DOI":"10.15420\/aer.2021.26","article-title":"ECG and pacing criteria for differentiating conduction system pacing from myocardial pacing","volume":"10","author":"Jastrzebski","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.cjca.2025.05.020_bib135","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.hrthm.2024.03.007","article-title":"Comparisons of long-term clinical outcomes with left bundle branch pacing, left ventricular septal pacing, and biventricular pacing for cardiac resynchronization therapy","volume":"21","author":"Zhu","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib136","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1093\/eurheartj\/ehac445","article-title":"Left bundle branch area pacing outcomes: the multicentre European MELOS study","volume":"43","author":"Jastrzebski","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib137","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib138","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2025.05.020_bib139","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0735-1097(03)00757-5","article-title":"A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome","volume":"42","author":"Nielsen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib140","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.hrthm.2016.09.027","article-title":"Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function","volume":"13","author":"Kiehl","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib141","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.hrthm.2014.05.040","article-title":"Incidence and predictors of right ventricular pacing-induced cardiomyopathy","volume":"11","author":"Khurshid","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib142","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.hrthm.2022.09.019","article-title":"Pacing-induced cardiomyopathy: a systematic review and meta-analysis of definition, prevalence, risk factors, and management","volume":"20","author":"Somma","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib143","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41591-024-03296-w","article-title":"People with cardiac pacemakers require multidisciplinary care","volume":"30","author":"Vernooy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib144","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jce.14490","article-title":"Network meta-analysis of His bundle, biventricular, or right ventricular pacing as a primary strategy for advanced atrioventricular conduction disease with normal or mildly reduced ejection fraction","volume":"31","author":"Fernandes","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.hrthm.2014.10.021","article-title":"Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice","volume":"12","author":"Sharma","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib146","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hrthm.2021.08.033","article-title":"Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: results from the Geisinger-Rush Conduction System Pacing Registry","volume":"19","author":"Sharma","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib147","article-title":"Clinical outcomes in patients with left bundle branch area pacing vs. right ventricular pacing for atrioventricular block","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib148","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of His bundle pacing compared to right ventricular pacing","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib149","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/europace\/euu011","article-title":"His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study","volume":"16","author":"Kronborg","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacc.2025.06.043","article-title":"Clinical outcomes of conduction system Pacing vs right ventricular septal pacing in atrioventricular block: The CSPACE Randomized Controlled Trial","volume":"86","author":"Chow","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131230","article-title":"Safety and efficacy of left bundle branch area pacing compared with right ventricular pacing in patients with bradyarrhythmia and conduction system disorders: systematic review and meta-analysis","volume":"390","author":"Leventopoulos","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib152","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hrthm.2017.10.014","article-title":"Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multicenter experience","volume":"15","author":"Sharma","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib153","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.hrthm.2017.04.003","article-title":"Permanent His-bundle pacing for cardiac resynchronization therapy: initial feasibility study in lieu of left ventricular lead","volume":"14","author":"Ajijola","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib154","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/heartjnl-2018-313415","article-title":"Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block","volume":"105","author":"Huang","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2025.05.020_bib155","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.hrthm.2015.03.048","article-title":"His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: a crossover design comparison","volume":"12","author":"Lustgarten","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib156","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.hrthm.2019.05.009","article-title":"On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: a secondary analysis of the His-SYNC pilot trial","volume":"16","author":"Upadhyay","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib157","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jacc.2019.04.026","article-title":"His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure","volume":"74","author":"Upadhyay","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib158","first-page":"1422","article-title":"A randomized trial of His pacing versus biventricular pacing in symptomatic HF patients with left bundle branch block (His-alternative)","volume":"7","author":"Vinther","year":"2021","journal-title":"JACC: Clinical Electrophysiology"},{"key":"10.1016\/j.cjca.2025.05.020_bib159","first-page":"1155","article-title":"Left bundle branch block\u2013induced cardiomyopathy: insights from left bundle branch pacing","volume":"7","author":"Ponnusamy","year":"2021","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib160","first-page":"849","article-title":"Cardiac resynchronization therapy in patients with nonischemic cardiomyopathy using left bundle branch pacing","volume":"6","author":"Huang","year":"2020","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib161","first-page":"135","article-title":"Left bundle branch area pacing for cardiac resynchronization therapy: results from the international LBBAP collaborative study group","volume":"7","author":"Vijayaraman","year":"2021","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib162","first-page":"319","article-title":"Left bundle branch pacing for cardiac resynchronization therapy: nonrandomized on-treatment comparison with His bundle pacing and biventricular pacing","volume":"37","author":"Wu","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib163","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.hrthm.2019.09.006","article-title":"Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block","volume":"16","author":"Zhang","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib164","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jacc.2022.07.019","article-title":"Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy","volume":"80","author":"Wang","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.hsr.2023.100104","article-title":"Conduction system pacing vs. biventricular pacing for cardiac resynchronization therapy in heart failure with reduced ejection fraction: an updated systematic review and meta-analysis","volume":"8","author":"Shrestha","year":"2023","journal-title":"Health Sciences Review"},{"key":"10.1016\/j.cjca.2025.05.020_bib166","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10840-024-01785-z","article-title":"Improved all-cause mortality with left bundle branch area pacing compared to biventricular pacing in cardiac resynchronization therapy: a meta-analysis","volume":"67","author":"Diaz","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib167","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.hrthm.2024.02.035","article-title":"Conduction system pacing versus biventricular pacing in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Ferreira Felix","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib168","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.118.038648","article-title":"Intracardiac delineation of septal conduction in left bundle-branch block patterns","volume":"139","author":"Upadhyay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib169","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2019.01.051","article-title":"Large variability in clinical judgement and definitions of left bundle branch block to identify candidates for cardiac resynchronisation therapy","volume":"286","author":"van Stipdonk","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib170","article-title":"Implementation of lead V8 as a simple non-invasive tool to improve patient selection in cardiac resynchronization therapy and guide left ventricular lead placement","volume":"27","author":"Joza","year":"2025","journal-title":"EP Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib171","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.013059","article-title":"Multicenter hemodynamic assessment of the LOT-CRT strategy: when does combining left bundle branch pacing and coronary venous pacing enhance resynchronization? Primary results of the CSPOT study","volume":"17","author":"Jastrzebski","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib172","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.hrthm.2025.04.026","article-title":"Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRT","volume":"22","author":"Upadhyay","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib173","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib174","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","article-title":"Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure","volume":"110","author":"Abraham","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib175","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib176","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib177","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/archinternmed.2011.247","article-title":"Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials","volume":"171","author":"Sipahi","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib178","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib179","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib180","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD trial","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2025.05.020_bib181","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.hrthm.2022.04.024","article-title":"Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: results from international LBBAP collaborative study group","volume":"19","author":"Vijayaraman","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib182","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1093\/eurheartj\/ehae656","article-title":"Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing","volume":"45","author":"Joza","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib183","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014253","article-title":"Feasibility and efficacy of His bundle pacing or left bundle pacing combined with atrioventricular node ablation in patients with persistent atrial fibrillation and implantable cardioverter-defibrillator therapy","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.05.020_bib184","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.hrthm.2022.03.1222","article-title":"Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of His-bundle vs left bundle branch area pacing leads","volume":"19","author":"Pillai","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib185","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.hrthm.2021.02.021","article-title":"Physiology-based electrocardiographic criteria for left bundle branch capture","volume":"18","author":"Jastrzebski","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib186","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacep.2021.03.013","article-title":"Novel criterion to diagnose left bundle branch capture in patients with left bundle branch block","volume":"7","author":"Vijayaraman","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib187","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.hrthm.2024.10.038","article-title":"Global R-wave peak time for diagnosis of left bundle branch capture","volume":"22","author":"Kielbasa","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib188","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/europace\/euab164","article-title":"The V6-V1 interpeak interval: a novel criterion for the diagnosis of left bundle branch capture","volume":"24","author":"Jastrzebski","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib189","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacep.2024.07.025","article-title":"Transseptal transition patterns during left bundle branch area lead implantation","volume":"10","author":"Jastrzebski","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib190","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacep.2021.02.018","article-title":"Evaluation of the criteria to distinguish left bundle branch pacing from left ventricular septal pacing","volume":"7","author":"Wu","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib191","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/europace\/euac276","article-title":"Combination of current and new electrocardiographic-based criteria: a novel score for the discrimination of left bundle branch capture","volume":"25","author":"Briongos-Figuero","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib192","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.hrthm.2022.07.029","article-title":"Masked right bundle branch conduction delay pattern during left bundle branch pacing","volume":"19","author":"Vijayaraman","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib193","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jtcvs.2017.11.093","article-title":"Outcome of tricuspid valve surgery in the presence of permanent pacemaker","volume":"155","author":"Saran","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2025.05.020_bib194","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1093\/ehjci\/jeab253","article-title":"Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper","volume":"23","author":"Lancellotti","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.05.020_bib195","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.amjcard.2015.09.041","article-title":"Effect of right ventricular pacing on right ventricular mechanics and tricuspid regurgitation in patients with high-grade atrioventricular block and sinus rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing study)","volume":"116","author":"Saito","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib196","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pace.12530","article-title":"Tricuspid regurgitation and implantable devices","volume":"38","author":"Al-Bawardy","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib197","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10840-017-0266-2","article-title":"Pacemaker-induced tricuspid regurgitation is uncommon immediately post-implantation","volume":"49","author":"Rothschild","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib198","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1540-8159.2000.tb00821.x","article-title":"Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study","volume":"23","author":"de Cock","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib199","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cjco.2019.10.002","article-title":"Lead-specific features predisposing to the development of tricuspid regurgitation after endocardial lead implantation","volume":"1","author":"Anvardeen","year":"2019","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2025.05.020_bib200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2022.10.160","article-title":"Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: from the national echocardiography database of Australia","volume":"370","author":"Offen","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib201","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000007005","article-title":"Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study","volume":"93","author":"Leibowitz","year":"2000","journal-title":"Cardiology"},{"key":"10.1016\/j.cjca.2025.05.020_bib202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1540-8191.2006.00251.x","article-title":"Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads","volume":"21","author":"Kucukarslan","year":"2006","journal-title":"J Card Surg"},{"key":"10.1016\/j.cjca.2025.05.020_bib203","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s00392-021-01812-3","article-title":"Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation","volume":"110","author":"Riesenhuber","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib204","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.echo.2013.06.006","article-title":"Proximal isovelocity surface area by single-beat three-dimensional colour Doppler echocardiography applied for tricuspid regurgitation quantification","volume":"26","author":"de Agustin","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2025.05.020_bib205","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jcin.2021.08.042","article-title":"Prevention of pacemaker lead-induced tricuspid regurgitation by transesophageal echocardiography guided implantation","volume":"14","author":"Gmeiner","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.hrthm.2022.10.027","article-title":"Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: effects on postoperative tricuspid regurgitation deterioration","volume":"20","author":"Hu","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib207","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.hrthm.2022.03.005","article-title":"Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing","volume":"19","author":"Li","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib208","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/pace.12701","article-title":"Tricuspid regurgitation following implantation of endocardial leads: incidence and predictors","volume":"38","author":"Lee","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib209","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010779","article-title":"Prospective evaluation of the correlation between gated cardiac computed tomography detected vascular fibrosis and ease of transvenous lead extraction","volume":"15","author":"Patel","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib210","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007124","article-title":"Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up","volume":"12","author":"Beurskens","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib211","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007375","article-title":"Leadless pacemakers and the tricuspid valve: can you believe it? Can this be true?","volume":"12","author":"Arkles","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib212","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2019.04.028","article-title":"Surgery does not improve survival in patients with isolated severe tricuspid regurgitation","volume":"74","author":"Axtell","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib213","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.jcin.2022.08.057","article-title":"Transcatheter aortic valve replacement with the latest-iteration self-expanding or balloon-expandable valves: the multicenter OPERA-TAVI registry","volume":"15","author":"Costa","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib214","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1093\/eurheartj\/ehz924","article-title":"Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis","volume":"41","author":"Faroux","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib215","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jcin.2023.02.003","article-title":"Impact of right ventricular pacing in patients with TAVR undergoing permanent pacemaker implantation","volume":"16","author":"Bruno","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib216","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jcmg.2016.11.020","article-title":"A highly predictive risk model for pacemaker implantation after TAVR","volume":"10","author":"Maeno","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.05.020_bib217","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/pace.13789","article-title":"Factors predicting persistence of AV nodal block in post-TAVR patients following permanent pacemaker implantation","volume":"42","author":"Lader","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib218","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcin.2014.07.022","article-title":"Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry","volume":"8","author":"Nazif","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib219","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jcin.2015.05.010","article-title":"Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation","volume":"8","author":"Hamdan","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/HCO.0000000000000609","article-title":"Predicting the future of TAVR: an obituary to open aortic valve replacement?","volume":"34","author":"Shreenivas","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib221","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jcin.2019.05.056","article-title":"Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement","volume":"12","author":"Jilaihawi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib222","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ipej.2024.03.003","article-title":"Depth of implantation in relation to membranous septum as a predictor of conduction disturbances after transcatheter aortic valve implantation","volume":"24","author":"Baraka","year":"2024","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.cjca.2025.05.020_bib223","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amjcard.2023.12.007","article-title":"Balloon-expandable versus self-expandable valve in transcatheter aortic valve replacement: a nation-wide study","volume":"213","author":"Sa","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib224","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacc.2014.04.033","article-title":"Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis","volume":"64","author":"Siontis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib225","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.acvd.2017.03.004","article-title":"Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: a retrospective study","volume":"110","author":"Becker","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2025.05.020_bib226","first-page":"E37","article-title":"Transcatheter aortic valve implantation in patients with right bundle-branch block: should prophylactic pacing be undertaken?","volume":"35","author":"Pavitt","year":"2023","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib227","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jcin.2017.05.030","article-title":"Clinical impact of baseline right bundle branch block in patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Auffret","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib228","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jcin.2018.04.016","article-title":"Arrhythmic burden as determined by ambulatory continuous cardiac monitoring in patients with new-onset persistent left bundle branch block following transcatheter aortic valve replacement: the MARE study","volume":"11","author":"Rodes-Cabau","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib229","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/europace\/euaa213","article-title":"Arrhythmic burden in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement: 2-year results of the MARE study","volume":"23","author":"Muntane-Carol","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib230","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcin.2012.03.004","article-title":"Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings","volume":"5","author":"Bagur","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib231","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2014.11.027","article-title":"Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death","volume":"65","author":"Urena","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib232","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.amjcard.2013.02.032","article-title":"Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve","volume":"111","author":"Meguro","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib233","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jce.13147","article-title":"Electrocardiographic predictors of long-term cardiac pacing dependency following transcatheter aortic valve implantation","volume":"28","author":"Naveh","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib234","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jcin.2018.04.011","article-title":"Immediate post-procedural 12-lead electrocardiography as predictor of late conduction defects after transcatheter aortic valve replacement","volume":"11","author":"Jorgensen","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.05.020_bib235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.hrthm.2014.10.023","article-title":"Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement","volume":"12","author":"Rivard","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib236","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10840-016-0218-2","article-title":"The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI","volume":"48","author":"Tovia-Brodie","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib237","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.amjcard.2018.02.015","article-title":"Utility of invasive electrophysiology studies in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation","volume":"121","author":"Rogers","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib238","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/pace.14225","article-title":"Predictors of high-degree conduction disturbances and pacemaker implantation after transcatheter aortic valve replacement: prognostic role of the electrophysiological study","volume":"44","author":"Ferreira","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib239","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/eurheartj\/ehae082","article-title":"Transcatheter treatment of the tricuspid valve: current status and perspectives","volume":"45","author":"Maisano","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib240","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jce.16227","article-title":"Outcomes of tricuspid regurgitation after lead extraction","volume":"35","author":"Shanafelt","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib241","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad300","article-title":"Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a \u2018heart team\u2019 approach","volume":"25","author":"Gabriels","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib242","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jacep.2017.05.007","article-title":"Complications and health care costs associated with transvenous cardiac pacemakers in a nationwide assessment","volume":"3","author":"Cantillon","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib243","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib244","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/13696998.2019.1652186","article-title":"Pacemaker complications and costs: a nationwide economic study","volume":"22","author":"Clementy","year":"2019","journal-title":"J Med Econ"},{"key":"10.1016\/j.cjca.2025.05.020_bib245","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.hrthm.2021.03.015","article-title":"Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker","volume":"18","author":"Hauser","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib246","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/jce.15863","article-title":"Leadless versus transvenous single-chamber ventricular pacemakers: 3 year follow-up of the Micra CED study","volume":"34","author":"Crossley","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib247","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1511643","article-title":"A leadless intracardiac transcatheter pacing system","volume":"374","author":"Reynolds","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib248","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jacep.2021.11.002","article-title":"Primary results on safety and efficacy from the LEADLESS II-phase 2 worldwide clinical trial","volume":"8","author":"Reddy","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib249","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10840-024-01791-1","article-title":"Early real-world implant experience with a helix-fixation ventricular leadless pacemaker","volume":"67","author":"Nair","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib250","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.hrthm.2017.05.017","article-title":"A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry","volume":"14","author":"Roberts","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib251","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacep.2019.10.017","article-title":"Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study","volume":"6","author":"Steinwender","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib252","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.hrthm.2022.08.033","article-title":"Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: primary results from the AccelAV study","volume":"20","author":"Chinitz","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib253","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa2300080","article-title":"A dual-chamber leadless pacemaker","volume":"388","author":"Knops","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib254","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/joa3.13145","article-title":"Cost-effectiveness of Micra VR leadless pacemaker in patients with bradycardia and atrial fibrillation in Australia","volume":"40","author":"Makino","year":"2024","journal-title":"J Arrhythm"},{"key":"10.1016\/j.cjca.2025.05.020_bib255","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2018.09.008","article-title":"Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects","volume":"207","author":"Mondesert","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2025.05.020_bib257","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.7326\/M22-1566","article-title":"Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous implantable cardioverter defibrillator implantations : a randomized, multicenter trial","volume":"175","author":"Healey","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib258","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib259","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib260","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jce.16150","article-title":"The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator","volume":"35","author":"Knight","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib261","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jce.16151","article-title":"Patient-reported quality of life and acceptance of the extravascular implantable cardioverter-defibrillator: results from pivotal study","volume":"35","author":"Sears","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib262","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjcn\/zvae067","article-title":"Device-specific quality of life: results from the ATLAS trial-avoid transvenous leads in appropriate subjects","volume":"23","author":"Carroll","year":"2024","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.cjca.2025.05.020_bib263","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib264","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","article-title":"Performance and safety of the extravascular implantable cardioverter-defibrillator through long-term follow-up: final results from the pivotal study","volume":"151","author":"Friedman","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.05.020_bib265","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae225","article-title":"Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access studies","volume":"26","author":"Sagi","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.05.020_bib266","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2401807","article-title":"A modular communicative leadless pacing-defibrillator system","volume":"391","author":"Knops","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.05.020_bib267","first-page":"1592","article-title":"Are we implanting too many primary-prevention implantable cardioverter-defibrillators?","volume":"40","author":"Pi","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.05.020_bib268","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.hrthm.2022.10.015","article-title":"Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics","volume":"20","author":"Sterns","year":"2023","journal-title":"Heart Rhythm"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25003794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25003794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:39:42Z","timestamp":1778200782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25003794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":267,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0828282X25003794"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.020","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}